期刊
PHARMACOLOGICAL RESEARCH
卷 60, 期 2, 页码 117-125出版社
ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
DOI: 10.1016/j.phrs.2009.03.008
关键词
Acylethanolamides; Anandamide; Apoptosis; Cannabinoid receptors; Colon cancer; Diarrhoea; Gut; Endocannabinoids; Inflammatory bowel disease; Intestinal motility; Phytocannabinoids; Visceral pain; Fatty acid amide hydrolase; Prostamides; Cannabidiol
资金
- PRIN
- Enrico and Enrica Sovena Foundation
Emerging evidence suggests that cannabinoids may exert beneficial effects in intestinal inflammation and cancer. Adaptive changes of the endocannabinoid system have been observed in intestinal biopsies from patients with inflammatory bowel disease and colon cancer. Studies on epithelial cells have shown that cannabinoids exert antiproliferative, antimetastatic and apoptotic effects as well as reducing cytokine release and promoting wound healing. In vivo, cannabinoids - via direct or indirect activation of CB1 and/or CB2 receptors - exert protective effects in well-established models of intestinal inflammation and colon cancer. Pharmacological elevation of endocannabinoid levels may be a promising strategy to counteract intestinal inflammation and colon cancer. (C) 2009 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据